查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1741356

主动脉瓣狭窄市场：依类型、依主动脉瓣类型、严重程度、依最终用户、地区

Aortic Stenosis Market, By Type, By Aortic Valve Types , By Severity, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

主动脉瓣狭窄市场规模预计在 2025 年达到 101.7 亿美元，预计到 2032 年将达到 204.6 亿美元，2025 年至 2032 年的复合年增长率为 10.5%。

分析范围 分析详细信息
基准年 2024 市场规模（2025年） 101.7亿美元
效能数据 2020-2024 预测期 2025-2032
预测期内的复合年增长率（2025-2032） 10.50% 预计金额（2032年） 204.6亿美元

主动脉瓣狭窄是指主动脉口（分隔左心室和主动脉）变窄。它会限制血液从心臟流向主动脉，从而减少心臟主泵腔每次收缩时泵入身体的血液量。主动脉瓣狭窄会在多年内缓慢进展，早期无症状，但随着病情加重，症状就会出现。随着口径进一步变窄，心臟必须更卖力地透过受限的口径泵送足够的血液，这会给心臟带来额外的负担。如果不及时治疗，最终会削弱和损害心肌。

市场动态

高血压、肥胖症和糖尿病等危险因子的盛行率上升对全球主动脉瓣狭窄市场的成长做出了重大贡献。主动脉瓣狭窄的常见原因包括老龄化、主动脉瓣内钙沉积使其变硬、风湿热和主动脉瓣先天性畸形。预计人口老化、技术进步和认识的提高将在预测期内推动全球主动脉瓣狭窄市场的成长。此外，预计医疗保健支出的增加也将在预测期内促进全球主动脉瓣狭窄市场的成长。预计经导管主动脉瓣置换术(TAVR) 的扩展、新兴市场的治疗和开发新药、个人化医疗以及远端医疗和远端监控将在预测期内为全球主动脉瓣狭窄市场提供成长机会。

然而，预计在预测期内，高昂的治疗费用、限制性的报销政策、可用性和意识的障碍以及临床和程序併发症将阻碍主动脉瓣狭窄市场的成长。

本报告的主要特点

  • 本报告对全球主动脉瓣狭窄市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
  • 它还强调了每个细分市场的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球主动脉瓣狭窄市场的主要企业是根据公司概况、产品系列、主要亮点、财务业绩和策略等参数列出的。
  • 透过本报告的见解，负责人和企业经营团队可以就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
  • 全球主动脉瓣狭窄市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球主动脉瓣狭窄市场的各种策略矩阵来促进他们的决策。

目录

第一章 分析目标与前提条件

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 人口老化
    • 医疗费用高昂
    • 经导管主动脉瓣置换术（TAVR）扩张术
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 管道分析
  • 波特五力分析
  • 企业合併（M&A）场景

4. 全球主动脉瓣狭窄市场：COVID-19感染疾病的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

第五章 全球主动脉瓣狭窄市场（依类型）（2020-2032）

  • 先天性主动脉瓣狭窄
  • 后天主动脉瓣狭窄

6. 全球主动脉瓣狭窄市场（依主动脉瓣类型划分）（2020-2032）

  • 机械主动脉瓣
  • 生物（组织瓣膜）主动脉瓣

7. 全球主动脉瓣狭窄市场依严重程度（2020-2032）

  • 轻度主动脉瓣狭窄
  • 中度主动脉瓣狭窄
  • 严重主动脉瓣狭窄

8. 全球主动脉瓣狭窄市场（依最终用户划分）（2020-2032 年）

  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

9. 全球主动脉瓣狭窄市场（按地区）（2020-2032）

  • 北美洲
  • 美国
  • 加拿大
  • 雨美国
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第十章 竞争格局

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc
  • Braile Biomedica
  • JenaValve Technology, Inc
  • Meril Life Sciences Pvt. Ltd
  • Micro Interventional Devices, Inc
  • egnite, Inc.

第 11 章 章节

  • 分析方法
  • 关于出版商
简介目录
Product Code: CMI6129

Aortic Stenosis Market is estimated to be valued at USD 10.17 Bn in 2025 and is expected to reach USD 20.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 10.17 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.50% 2032 Value Projection: USD 20.46 Bn

Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.

Market Dynamics

The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve. Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.

However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the global aortic stenosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global aortic stenosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomedica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market

Aortic Stenosis Market Detailed Segmentation:

  • By Type:
    • Congenital Aortic Stenosis
    • Acquired Aortic Stenosis
  • By Aortic Valve Types:
    • Mechanical Aortic Valves
    • Bioprosthetic (Tissue) Aortic Valves
  • By Severity:
    • Mild Aortic Stenosis
    • Moderate Aortic Stenosis
    • Severe Aortic Stenosis
  • By End User:
    • Hospital
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profile:
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • Braile Biomedica
    • JenaValve Technology, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Micro Interventional Devices, Inc.
    • gnite, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Aortic Valve Types
    • Market Snapshot, By Severity
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Aging Population
    • High Cost of Treatment
    • Transcatheter Aortic Valve Replacement (TAVR) Expansion
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • Pipeline Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Aortic Stenosis Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Aortic Stenosis Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Congenital Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Acquired Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Aortic Stenosis Market, By Aortic Valve Types, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Mechanical Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Bioprosthetic (Tissue) Aortic Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Aortic Stenosis Market, By Severity, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Mild Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Moderate Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Severe Aortic Stenosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Aortic Stenosis Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Aortic Stenosis Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2028
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • U.S.
  • Canada
  • Lain America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2028, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Edwards Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CryoLife, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • JenaValve Technology, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Meril Life Sciences Pvt. Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Micro Interventional Devices, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • egnite, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us